SCHEMBL30906468

CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@@H](N)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)NCC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)O)C(C)C)[C@@H](C)CC

nearest known ligand 0.68

Predicted protein targets (top 9)

	gene	UniProt	supporting neighbours	confidence
▸	NPY2R	P49146	8/20	0.68

▸	NPY4R	P50391	8/20	0.68

▸	NPY5R	Q15761	8/20	0.68

▸	NPY1R	P25929	6/20	0.68

▸	CXCR4	P61073	3/20	0.65

▸	GLP1R	P43220	6/20	0.61

▸	RXFP1	Q9HBX9	1/20	0.60

▸	ECE1	P42892	1/20	0.60

▸	MUS81	Q96NY9	1/20	0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL30824281	0.89	NPY2R (0.70)	NPY2RNPY4RNPY5RNPY1RCXCR4
SCHEMBL29430200	0.89	NPY2R (0.74)	NPY2RNPY4RNPY5RNPY1RGLP1R
SCHEMBL30607459	0.88	CXCR4 (0.62)	NPY2RNPY4RNPY5RNPY1RCXCR4
SCHEMBL30721554	0.88	NPY2R (0.76)	NPY2RNPY4RNPY5RNPY1RCXCR4
SCHEMBL30081077	0.87	NPY2R (0.67)	NPY2RNPY4RNPY5RNPY1RCXCR4
SCHEMBL29523146	0.87	RXFP1 (0.64)	NPY2RNPY4RNPY5RNPY1RCXCR4
SCHEMBL29430205	0.87	NPY1R (0.65)	NPY2RNPY4RNPY5RNPY1RCXCR4
SCHEMBL30816280	0.87	NPY1R (0.65)	NPY2RNPY4RNPY5RNPY1RCXCR4
SCHEMBL31182745	0.87	NPY1R (0.71)	NPY2RNPY4RNPY5RNPY1RCXCR4
SCHEMBL30712904	0.86	CXCR4 (0.68)	NPY2RNPY4RNPY5RNPY1RCXCR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
EP-4598964-A2	ANTI-IGE ANTIBODIES	Abwiz Bio, Inc. (US)	2025-08-13	—	—	EP	disclosed
US-20240182599-A1	ANTI-IGE ANTIBODIES	ABWIZ BIO, INC.	2024-06-06	—	—	US	disclosed
WO-2024076785-A2	ANTI-IGE ANTIBODIES	ABWIZ BIO, INC. (US)	2024-04-11	—	—	WO	disclosed